BioNexus Gene Lab Corp. Allowance for Loan and Lease Losses, Write-offs
BioNexus Gene Lab Corp. (BGLC) reported Allowance for Loan and Lease Losses, Write-offs of $40.12 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Notes › Credit Losses
us-gaap:AllowanceForLoanAndLeaseLossesWriteOffs · last filed 2025-05-15
- BioNexus Gene Lab Corp. allowance for loan and lease losses, write-offs for the quarter ending 2025-03-31 was $40.12K, a 66.69% decline year-over-year.
- BioNexus Gene Lab Corp. allowance for loan and lease losses, write-offs for the quarter ending 2024-12-31 was $760.69K.
- BioNexus Gene Lab Corp. allowance for loan and lease losses, write-offs for the quarter ending 2024-09-30 was $2.47K, a 99.77% decline year-over-year.
- BioNexus Gene Lab Corp. allowance for loan and lease losses, write-offs for the quarter ending 2024-06-30 was -$99.00, a 100.03% decline year-over-year.
- BioNexus Gene Lab Corp. allowance for loan and lease losses, write-offs for fiscal 2024 was $883.53K, a 6.29% decline from fiscal 2023.
- BioNexus Gene Lab Corp. allowance for loan and lease losses, write-offs for fiscal 2023 was $942.80K.
- BioNexus Gene Lab Corp. allowance for loan and lease losses, write-offs for fiscal 2022 was $0.00.
- BioNexus Gene Lab Corp. allowance for loan and lease losses, write-offs for fiscal 2020 was $2.66K.
| Period end | Allowance for Loan and Lease Losses, Write-offs 3 month | Allowance for Loan and Lease Losses, Write-offs 6 month | Allowance for Loan and Lease Losses, Write-offs 9 month | Allowance for Loan and Lease Losses, Write-offs 12 month | Allowance for Loan and Lease Losses, Write-offs 12 month as first filed |
|---|---|---|---|---|---|
| 2025-03-31 | $40.12K 10-Q · filed 2025-05-15 | $800.81K derived: sum of 2 quarters · filed 2025-05-15 | $803.29K derived: sum of 3 quarters · filed 2025-05-15 | $803.19K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2024-12-31 | $760.69K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $763.16K derived: sum of 2 quarters · filed 2025-04-15 | $763.06K derived: sum of 3 quarters · filed 2025-04-15 | $883.53K 10-K · filed 2025-04-15 | |
| 2024-09-30 | $2.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | $2.37K derived: sum of 2 quarters · filed 2024-11-15 | $122.84K 10-Q · filed 2024-11-15 | -$306.93K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2024-06-30 | -$99.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $120.37K 10-Q · filed 2024-08-14 | -$309.40K derived: sum of 3 quarters · filed 2025-05-15 | $771.23K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2024-03-31 | $120.47K 10-Q · filed 2025-05-15 | -$309.30K derived: sum of 2 quarters · filed 2025-05-15 | $771.33K derived: sum of 3 quarters · filed 2025-05-15 | $1.06M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$429.77K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $650.86K derived: sum of 2 quarters · filed 2025-04-15 | $942.80K derived: sum of 3 quarters · filed 2025-04-15 | $942.80K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | $1.37M derived: sum of 2 quarters · filed 2024-11-15 | $1.37M 10-Q · filed 2024-11-15 | ||
| 2023-06-30 | $291.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $291.94K 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | ||||
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | $0.00 10-Q · filed 2022-08-15 | $3.81K 10-K · filed 2022-04-06 | |||
| 2020-12-31 | $2.66K 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |